$0.19
$0.00 (0.00%)
End-of-day quote: 05/15/2024
ASX:MAP
Microba Life Sciences Annual Report
| Year | Year | 2023 | 2022 | ||
|---|---|---|---|---|---|
| Rev. | Revenue |
|
$5.42M | $4.69M | |
| GM % | Gross Margin % |
|
49.41% | 50.46% | |
| OM | Operating Margin |
|
0.00% | 0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $-0.04 | $-0.05 |
| Div. | Dividends |
|
$0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | |
| Sha. | Shares |
|
344.14m | 274.36m | |
| OCF | Operating Cash Flow |
|
$-12.39M | $-10.45M | |
| FCF | Free Cash Flow |
|
$-10.60M | $-12.32M | |
| FCFS | Free Cash Flow Per Share |
|
$-0.05 | $-0.06 |
